Serum N-telopeptide (NTx) is material in type-1 collagen--the protein of connective and other tissue--that is released when cells called osteoclasts function in the breakdown and resorption of bone tissue. It is a marker of bone resorption. These investigators wanted to determine whether NTx might act as a marker for bone metastases in advanced prostate cancer.
They took sera from 39 men with prostate cancer and a positive bone scan, and from 45 men with prostate cancer and a negative bone scan. Serum NTx levels were compared to serum PSA levels between the two groups. They found that serum NTx levels were a very significant predictor of bone metastases in men with prostate cancer, exceeding the predictive potential of the PSA test.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.